enGene Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $221.5M
Liabilities Breakdown FY2025
Total Liabilities: $53.8M
Asset Breakdown
Total Assets: $221.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $50.2M | 22.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.5M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $168.8M | 76.2% |
Liabilities Breakdown
Total Liabilities: $53.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.7M | 12.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $47.1M | 87.6% |